Advertisement

Topics

Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board / Dr. Joseph Borovsky and Dr. Leonid Lurya Appointed to Scientific Advisory Board

08:01 EST 9 Nov 2017 | FinanzNachrichten

VANCOUVER, BC -- (Marketwired) -- 11/09/17 -- Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce the signing of a Binding Letter of Intent with Thrudermic,...

Original Article: Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board / Dr. Joseph Borovsky and Dr. Leonid Lurya Appointed to Scientific Advisory Board

NEXT ARTICLE

More From BioPortfolio on "Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board / Dr. Joseph Borovsky and Dr. Leonid Lurya Appointed to Scientific Advisory Board"

Advertisement
Quick Search
Advertisement
Advertisement